Carcinogenesis, Vol. 21, No. 5, 857-864,
May 2000
© 2000 Oxford University Press
Commentaries |
Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis
Herbert Irving Comprehensive Cancer Center and Departments of Medicine, Genetics and Development and Public Health, Columbia University College of Physicians and Surgeons, 701 West 168th Street, New York, NY 10032, USA
Abstract
The multistage process of carcinogenesis involves the progressive acquisition of mutations, and epigenetic abnormalities in the expression, of multiple genes that have highly diverse functions. An important group of these genes are involved in cell cycle control. Thus, cyclin D1 is frequently overexpressed in a varety of human cancers. Cylin D1 plays a critical role in carcinogenesis because (i) overexpression enhances cell transformation and tumorigenesis, and enhances the amplification of other genes, and (ii) an antisense cyclin D1 cDNA reverts the malignant phenotype of carcinoma cells. Therefore, cyclin D1 may be a useful biomarker in molecular epidemiology studies, and inhibitors of its function may be useful in both cancer chemoprevention and therapy. We discovered a paradoxical increase in the cell cycle inhibitors protein p27Kip1 in a subset of human cancers, and obtained evidence for homeostatic feedback loops between cyclins D1 or E and p27Kip1. Furthermore, derivatives of HT29 colon cancer cells with increased levels of p27Kip1 showed increased sensitivity to induction of differentiation. This may explain why decreased p27Kip1 in a subset of human cancers is associated with a high grade (poorly differentiated) histology and poor prognosis. Agents that increase cellular levels of p27Kip1 may, therefore, also be useful in cancer therapy. Using an antisense Rb oligonucleotide we obtained evidence that the paradoxical increase in pRb often seen in human colon cancers protects these cells from growth inhibition and apopotosis. On the basis of these, and other findings, we hypothesize that homeostatic feedback mechanisms play a critical role in multistage carcinogenesis. Furthermore, because of their bizarre circuitry, cancer cells suffer from `gene addiction' and `gene hypersensitivity' disorders that might be exploited in both cancer prevention and chemotherapy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. WARENIUS, L. KYRITSI, I. GRIERSON, A. HOWARTH, L. SEABRA, M. JONES, C. THOMAS, P. BROWNING, and R. WHITE Spontaneous Regression of Human Cancer Cells In Vitro: Potential Role of Disruption of Cdk1/Cdk4 Co-expression Anticancer Res, June 1, 2009; 29(6): 1933 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Foster, Z. Gatalica, S. Lilleberg, G. Haynatzki, and B. W. Loggie Novel and Existing Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor are Predictors of Optimal Resectability in Malignant Peritoneal Mesothelioma Ann. Surg. Oncol., January 1, 2009; 16(1): 152 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. VanMeter, A. S. Rodriguez, E. D. Bowman, J. Jen, C. C. Harris, J. Deng, V. S. Calvert, A. Silvestri, C. Fredolini, V. Chandhoke, et al. Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer: Differential Epidermal Growth Factor Receptor (EGPR) Phosphorylation Events Associated with Mutated EGFR Compared with Wild Type Mol. Cell. Proteomics, October 1, 2008; 7(10): 1902 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wei, H.-C. Yang, H.-C. Chuang, J. Yang, S. K. Kulp, P.-J. Lu, M.-D. Lai, and C.-S. Chen A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer Cells J. Biol. Chem., September 26, 2008; 283(39): 26759 - 26770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. B. Weinstein, A. Joe, and D. Felsher Oncogene Addiction Cancer Res., May 1, 2008; 68(9): 3077 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Sharma and J. Settleman Oncogene addiction: setting the stage for molecularly targeted cancer therapy Genes & Dev., December 15, 2007; 21(24): 3214 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zundelevich, G. Elad-Sfadia, R. Haklai, and Y. Kloog Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid) Mol. Cancer Ther., June 1, 2007; 6(6): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Davis Nutritional Interactions: Credentialing of Molecular Targets for Cancer Prevention Experimental Biology and Medicine, February 1, 2007; 232(2): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hulit, R. J. Lee, Z. Li, C. Wang, S. Katiyar, J. Yang, A. A. Quong, K. Wu, C. Albanese, R. Russell, et al. p27Kip1 Repression of ErbB2-Induced Mammary Tumor Growth in Transgenic Mice Involves Skp2 and Wnt/{beta}-Catenin Signaling. Cancer Res., September 1, 2006; 66(17): 8529 - 8541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yasui, H. Yamamoto, C. Y. Ngan, B. Damdinsuren, Y. Sugita, H. Fukunaga, J. Gu, M. Maeda, I. Takemasa, M. Ikeda, et al. Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization Clin. Cancer Res., August 1, 2006; 12(15): 4720 - 4729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Sharma, M. A. Fischbach, D. A. Haber, and J. Settleman "Oncogenic Shock": Explaining Oncogene Addiction through Differential Signal Attenuation. Clin. Cancer Res., July 15, 2006; 12(14): 4392s - 4395s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. El-Bayoumy, A. Das, B. Narayanan, N. Narayanan, E. S. Fiala, D. Desai, C. V. Rao, S. Amin, and R. Sinha Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer Carcinogenesis, July 1, 2006; 27(7): 1369 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Hizli, A. R. Black, M. A. Pysz, and J. D. Black Protein Kinase C {alpha} Signaling Inhibits Cyclin D1 Translation in Intestinal Epithelial Cells J. Biol. Chem., May 26, 2006; 281(21): 14596 - 14603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Seki, H. Yamamoto, C. Yee Ngan, M. Yasui, N. Tomita, K. Kitani, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, et al. Construction of a novel DNA decoy that inhibits the oncogenic {beta}-catenin/T-cell factor pathway. Mol. Cancer Ther., April 1, 2006; 5(4): 985 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Ouyang, J. Li, Q. Ma, and C. Huang Essential roles of PI-3K/Akt/IKK{beta}/NF{kappa}B pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells Carcinogenesis, April 1, 2006; 27(4): 864 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of I{kappa}B{alpha} Kinase and Akt Activation Mol. Pharmacol., January 1, 2006; 69(1): 195 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Ouyang, Q. Ma, J. Li, D. Zhang, Z.-g. Liu, A. K. Rustgi, and C. Huang Cyclin D1 Induction through I{kappa}B Kinase {beta}/Nuclear Factor-{kappa}B Pathway Is Responsible for Arsenite-Induced Increased Cell Cycle G1-S Phase Transition in Human Keratinocytes Cancer Res., October 15, 2005; 65(20): 9287 - 9293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Blackburn Telomerase and Cancer: Kirk A. Landon - AACR Prize for Basic Cancer Research Lecture Mol. Cancer Res., September 1, 2005; 3(9): 477 - 482. [Full Text] [PDF]
|
|
|
|
|
|
S. Li, J. Crothers, C. M. Haqq, and E. H. Blackburn Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA J. Biol. Chem., June 24, 2005; 280(25): 23709 - 23717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takada, Y. Kobayashi, and B. B. Aggarwal Evodiamine Abolishes Constitutive and Inducible NF-{kappa}B Activation by Inhibiting I{kappa}B{alpha} Kinase Activation, Thereby Suppressing NF-{kappa}B-regulated Antiapoptotic and Metastatic Gene Expression, Up-regulating Apoptosis, and Inhibiting Invasion J. Biol. Chem., April 29, 2005; 280(17): 17203 - 17212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Garcia-Espana, E. Salazar, T.-T. Sun, X.-R. Wu, and A. Pellicer Differential Expression of Cell Cycle Regulators in Phenotypic Variants of Transgenically Induced Bladder Tumors: Implications for Tumor Behavior Cancer Res., February 15, 2005; 65(4): 1150 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kentsis, I. Topisirovic, B. Culjkovic, L. Shao, and K. L. B. Borden Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap PNAS, December 28, 2004; 101(52): 18105 - 18110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Hofseth The adaptive imbalance to genotoxic stress: genome guardians rear their ugly heads Carcinogenesis, October 1, 2004; 25(10): 1787 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimizu, M. Suzui, A. Deguchi, J. T. E. Lim, D. Xiao, J. H. Hayes, K. P. Papadopoulos, and I. B. Weinstein Synergistic Effects of Acyclic Retinoid and OSI-461 on Growth Inhibition and Gene Expression in Human Hepatoma Cells Clin. Cancer Res., October 1, 2004; 10(19): 6710 - 6721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF]
|
|
|
|
|
|
S. Shishodia and B. B. Aggarwal Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates Activation of Cigarette Smoke-Induced Nuclear Factor (NF)-{kappa}B by Suppressing Activation of I-{kappa}B {alpha} Kinase in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of Cyclin D1, COX-2, and Matrix Metalloproteinase-9 Cancer Res., July 15, 2004; 64(14): 5004 - 5012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Huycke and H. R. Gaskins Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Benzeno, G. Narla, J. Allina, G. Z. Cheng, H. L. Reeves, M. S. Banck, J. A. Odin, J. A. Diehl, D. Germain, and S. L. Friedman Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1 Cancer Res., June 1, 2004; 64(11): 3885 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. Bateman, D. Tan, R. G. Pestell, J. D. Black, and A. R. Black Intestinal Tumor Progression Is Associated with Altered Function of KLF5 J. Biol. Chem., March 26, 2004; 279(13): 12093 - 12101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Suzui, M. Shimizu, M. Masuda, J. T. E. Lim, N. Yoshimi, and I. B. Weinstein Acyclic retinoid activates retinoic acid receptor {beta} and induces transcriptional activation of p21CIP1 in HepG2 human hepatoma cells Mol. Cancer Ther., March 1, 2004; 3(3): 309 - 316. [Abstract] [Full Text]
|
|
|
|
|
|
M. Shimizu, M. Suzui, A. Deguchi, J. T. E. Lim, and I. B. Weinstein Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells Clin. Cancer Res., February 1, 2004; 10(3): 1130 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Gammon, M. B. Terry, N. Arber, W.-H. Chow, H. A. Risch, T. L. Vaughan, J. B. Schoenberg, S. T. Mayne, J. L. Stanford, R. Dubrow, et al. Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1: A Population-Based Study Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 34 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, S. Lyle, Y. Liu, B. Solky, and G. Cotsarelis Differential Expression of Cyclin D1 in the Human Hair Follicle Am. J. Pathol., September 1, 2003; 163(3): 969 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shishodia, P. Potdar, C. G. Gairola, and B. B. Aggarwal Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-{kappa}B activation through inhibition of I{kappa}B{alpha} kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 Carcinogenesis, July 1, 2003; 24(7): 1269 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood, February 1, 2003; 101(3): 1053 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Biswas, K. J. Martin, C. McAlister, A. P. Cruz, E. Graner, S.-c. Dai, and A. B. Pardee Apoptosis Caused by Chemotherapeutic Inhibition of Nuclear Factor-{kappa}B Activation Cancer Res., January 15, 2003; 63(2): 290 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. McAllister, M. Becker-Hapak, G. Pintucci, M. Pagano, and S. F. Dowdy Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions Mol. Cell. Biol., January 1, 2003; 23(1): 216 - 228. [Abstract] [Full Text]
|
|
|
|
|
|
M. Suzui, M. Masuda, J. T. E. Lim, C. Albanese, R. G. Pestell, and I. B. Weinstein Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p21CIP1 and Inhibition of Expression of Cyclin D1 Cancer Res., July 15, 2002; 62(14): 3997 - 4006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Bindra, J. R. Vasselli, R. Stearman, W. M. Linehan, and R. D. Klausner VHL-mediated Hypoxia Regulation of Cyclin D1 in Renal Carcinoma Cells Cancer Res., June 1, 2002; 62(11): 3014 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Witschi, I. Espiritu, M. Suffia, and K. E. Pinkerton Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents Carcinogenesis, February 1, 2002; 23(2): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Madewell, S. Griffey, J. Walls, and R. Gandour-Edwards Reduced Expression of Cyclin-dependent Kinase Inhibitor p27Kip1 in Feline Lymphoma Vet. Pathol., November 1, 2001; 38(6): 698 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Simbulan-Rosenthal, D. H. Ly, D. S. Rosenthal, G. Konopka, R. Luo, Z.-Q. Wang, P. G. Schultz, and M. E. Smulson Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase PNAS, September 29, 2000; (2000) 200285797. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Simbulan-Rosenthal, D. H. Ly, D. S. Rosenthal, G. Konopka, R. Luo, Z.-Q. Wang, P. G. Schultz, and M. E. Smulson Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase PNAS, October 10, 2000; 97(21): 11274 - 11279. [Abstract] [Full Text] [PDF]
|
|